Advancements in therapeutic paradigm: Harnessing IL‐17A inhibitor secukinumab to ameliorate psoriasis vulgaris in the presence of resistant pericardial effusion.

Autor: Tan, Qing, Xu, Lifeng, Wu, Ruoxi, Lin, Zeying, Huang, Wenhui, Yu, Shuilian
Zdroj: Rheumatology & Autoimmunity; Jun2024, Vol. 4 Issue 2, p126-128, 3p
Databáze: Complementary Index
Externí odkaz: